𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-inflammatory function of Withangulatin A by targeted inhibiting COX-2 expression via MAPK and NF-κB pathways

✍ Scribed by Lijuan Sun; Jianwen Liu; Daling Cui; Jiyu Li; Youjun Yu; Lei Ma; Lihong Hu


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
328 KB
Volume
109
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Withangulatin A (WA), an active component isolated from Physalis angulata L., has been reported to possess anti-tumor and trypanocidal activities in model systems via multiple biochemical mechanisms. The aim of this study is to investigate its anti-inflammatory potential and the possible underlying mechanisms. In the current study, WA significantly suppressed mice T lymphocytes proliferation stimulated with LPS in a dose-and time-dependent manner and inhibited pro-inflammation cytokines (IL-2, IFN-g, and IL-6) dramatically. Moreover, WA targeted inhibited COX-2 expression mediated by MAPKs and NF-kB nuclear translocation pathways in mice T lymphocytes, and this result was further confirmed by the COX-1/2 luciferase reporter assay. Intriguingly, administration of WA inhibited the extent of mice ear swelling and decreased pro-inflammatory cytokines production in mice blood serum. Based on these evidences, WA influences the mice T lymphocytes function through targeted inhibiting COX-2 expression via MAPKs and NF-kB nuclear translocation signaling pathways, and this would make WA a strong candidate for further study as an anti-inflammatory agent.


📜 SIMILAR VOLUMES


Anti-inflammatory effect of pelubiprofen
✍ Ji-Sun Shin; Seung Ryel Baek; Se-il Sohn; Young-wuk Cho; Kyung-Tae Lee 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Pelubiprofen is a non-steroidal anti-inflammatory drugs (NSAIDs) that is related both structurally and pharmacologically to ibuprofen. Antiinflammatory properties of ibuprofen are due to its ability to both decrease prostaglandin synthesis by inhibiting the activities of cyclooxygenases (COXs) and I